| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a5ee27510e9698b22024fe361b2ca14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-02 |
| filingDate |
2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b9f7194a88a253acde1fe5f68ded48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e39e26c463cd66b2b59609035fcbe018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1d8aef53b3673489a2dcb94ff972f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a440e8fd0f36056b9e3b6730d7d810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09ac8cf9f3cfeb9731b3fc0a63d57ad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33b614a258267f3bb5491e9ffb21c7fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7696dff8c9bcceb3a9c3a239d96d9ae |
| publicationDate |
2022-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-216169073-U |
| titleOfInvention |
Double-channel targeted coating drug stent |
| abstract |
The utility model provides a double-channel targeted coating drug stent which comprises a stent body, wherein the outer side surface of the stent body is provided with a plurality of grooves, and first drug layers are filled in the grooves; the inner side surface of the bracket body is covered with a second medicine layer; the first medicine layer is also wrapped outside the bracket body and the second medicine layer. The double-channel targeted coating drug stent disclosed by the utility model can effectively inhibit intimal hyperplasia, and promote targeted homing formation and re-endothelialization of CD34+ cells on the inner surface of the stent cavity, so that the effect of reducing the occurrence of long-term thrombosis after stent implantation is achieved. |
| priorityDate |
2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |